Microbiological assessment of polymyxin B components tested alone and in combination

Zahra Kassamali; Randall A. Prince; Larry H. Danziger; John C. Rotschafer; Paul R. Rhomberg; Ronald N. Jones

doi:10.1128/AAC.01021-15

Microbiological assessment of polymyxin B components tested alone and in combination

Zahra Kassamali, Randall A. Prince, Larry H. Danziger, John C. Rotschafer, Paul R. Rhomberg, Ronald N. Jones

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

We investigated the antimicrobial activity of four polymyxin B components, B1, B2, B3, and isoleucine (Ile)-B1, individually and in combination. B3 was the most active agent against all organisms tested except Acinetobacter baumannii, for which Ile-B1 was most active. One combination met the criteria for synergy, B3 plus Ile-B1. No combinations exhibited antagonism. The dominant components of polymyxin B products (B1 and B2) were associated with the lowest probability of improved antibacterial activity when combined.

Original language	English (US)
Pages (from-to)	7823-7825
Number of pages	3
Journal	Antimicrobial agents and chemotherapy
Volume	59
Issue number	12
DOIs	https://doi.org/10.1128/AAC.01021-15
State	Published - Dec 1 2015

Bibliographical note

Publisher Copyright:
© 2015, American Society for Microbiology. All Rights Reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1128/AAC.01021-15

Cite this

@article{54d2ec42bfbc420bbfd8664e44c1f939,

title = "Microbiological assessment of polymyxin B components tested alone and in combination",

abstract = "We investigated the antimicrobial activity of four polymyxin B components, B1, B2, B3, and isoleucine (Ile)-B1, individually and in combination. B3 was the most active agent against all organisms tested except Acinetobacter baumannii, for which Ile-B1 was most active. One combination met the criteria for synergy, B3 plus Ile-B1. No combinations exhibited antagonism. The dominant components of polymyxin B products (B1 and B2) were associated with the lowest probability of improved antibacterial activity when combined.",

author = "Zahra Kassamali and Prince, {Randall A.} and Danziger, {Larry H.} and Rotschafer, {John C.} and Rhomberg, {Paul R.} and Jones, {Ronald N.}",

year = "2015",

month = dec,

day = "1",

doi = "10.1128/AAC.01021-15",

language = "English (US)",

volume = "59",

pages = "7823--7825",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "12",

}

TY - JOUR

T1 - Microbiological assessment of polymyxin B components tested alone and in combination

AU - Kassamali, Zahra

AU - Prince, Randall A.

AU - Danziger, Larry H.

AU - Rotschafer, John C.

AU - Rhomberg, Paul R.

AU - Jones, Ronald N.

PY - 2015/12/1

Y1 - 2015/12/1

N2 - We investigated the antimicrobial activity of four polymyxin B components, B1, B2, B3, and isoleucine (Ile)-B1, individually and in combination. B3 was the most active agent against all organisms tested except Acinetobacter baumannii, for which Ile-B1 was most active. One combination met the criteria for synergy, B3 plus Ile-B1. No combinations exhibited antagonism. The dominant components of polymyxin B products (B1 and B2) were associated with the lowest probability of improved antibacterial activity when combined.

AB - We investigated the antimicrobial activity of four polymyxin B components, B1, B2, B3, and isoleucine (Ile)-B1, individually and in combination. B3 was the most active agent against all organisms tested except Acinetobacter baumannii, for which Ile-B1 was most active. One combination met the criteria for synergy, B3 plus Ile-B1. No combinations exhibited antagonism. The dominant components of polymyxin B products (B1 and B2) were associated with the lowest probability of improved antibacterial activity when combined.

UR - http://www.scopus.com/inward/record.url?scp=84954546047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954546047&partnerID=8YFLogxK

U2 - 10.1128/AAC.01021-15

DO - 10.1128/AAC.01021-15

M3 - Article

C2 - 26392511

AN - SCOPUS:84954546047

VL - 59

SP - 7823

EP - 7825

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -

Microbiological assessment of polymyxin B components tested alone and in combination

Abstract

Bibliographical note

UN SDGs

Access

Other files and links

Fingerprint

Cite this